First Time Loading...
S

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505

Watchlist Manager
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Watchlist
Price: 7.73 CNY 0.39% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

There are no price targets for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors:
Price Targets
603229
Zhejiang Ausun Pharmaceutical Co Ltd
79% Upside
T
600488
Tianjin Tianyao Pharmaceuticals Co Ltd
37% Upside
T
TSPC
Tempo Scan Pacific Tbk PT
14% Downside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
603229
Zhejiang Ausun Pharmaceutical Co Ltd
79% Upside
T
600488
Tianjin Tianyao Pharmaceuticals Co Ltd
37% Upside
T
TSPC
Tempo Scan Pacific Tbk PT
14% Downside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
S
SDZ
Sandoz Group AG
15% Upside
326030
SK Biopharmaceuticals Co Ltd
29% Upside
P
PPLPHARMA
Piramal Pharma Ltd
9% Upside
K
4521
Kaken Pharmaceutical Co Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Revenue forecast
is not available for
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Operating Income
Forecast

Operating Income Estimate
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

For the last 5 years the compound annual growth rate for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 5 years is -4%.

-1%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's stock price target?
Not Available

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-4%

For the last 5 years the compound annual growth rate for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 5 years is -4%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.